Eli Lilly
Global pharmaceutical company with a corporate venture arm (Lilly Ventures) investing in early-stage biotech, health tech, and life sciences companies.
Indianapolis, United States · 83+ investments · 62 portfolio companies
- Headquarters
- Indianapolis, United States
- Founded
- 2002
- Website
- lilly.com
- AUM
- $300.0M
- Portfolio Companies
- 62
- Total Investments
- 83
- Last Investment
- Sep 2026
- Geographic Focus
- Global, United States, global
Indexed holds 62 portfolio companies and 83 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Eli Lilly is a Venture Capital firm based in Indianapolis, United States. It has made 83 investments, including DELFI Diagnostics, Arkuda Therapeutics and Nucleix. Focus areas include Biotech and Digital Health.
Fund Family
Portfolio62
Showing 48 of 62 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 110 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Hedge Fund ×3 · Corporate VC ×2 · 78 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/eli-lilly"><img src="https://indexed.vc/api/badge/investor/eli-lilly" alt="Eli Lilly on Indexed.vc" width="260" height="76" /></a>